Effect of population breast screening on breast cancer mortality to 2005 in england and wales: A nested case-control study within a cohort of one million women

Journal of Medical Screening

Volumn 25, Issue 2, 2018, Pages 76-81

  Johns, Louise E ^a   Swerdlow, Anthony J ^a   Moss, Susan M ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Breast cancer; Case control; Evaluation; Mortality; Screening

Indexed keywords

BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; EARLY CANCER DIAGNOSIS; ENGLAND; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; MORTALITY; NATIONAL HEALTH SERVICE; ODDS RATIO; OUTCOME ASSESSMENT; STANDARDS; STATISTICAL MODEL; WALES;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); STATE MEDICINE; WALES;

EID: 85055723373     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141317713232     Document Type: Article

References (46)

1. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-1786.
2. Health & Social Care Information Centre. Breast Screening Programme-England, 2014-15, www.hscic.gov.uk (2016, accessed 6 March 2016).
3. Jorgensen KJ and Gotzsche PC. Breast cancer: updated screening guidelines-much ado about small improvements. Nat Rev Clin Oncol 2016; 13: 139-140.
4. Bleyer A, Baines C and Miller AB. Impact of screening mammography on breast cancer mortality. Int J Cancer 2016; 138: 2003-2012.
5. Paci E, Broeders M, Hofvind S, et al. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms. Cancer Epidemiol Biomarkers Prev 2014; 23: 1159-1163.
6. Broeders M, Moss S, Nystrom L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012; 19: 14-25.
7. Palli D, Del Turco MR, Buiatti E, et al. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 1986; 38: 501-504.
8. Miltenburg GA, Peeters PH, Fracheboud J, et al. Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom. Br J Cancer 1998; 78: 962-965.
9. Fielder HM, Warwick J, Brook D, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 2004; 11: 194-198.
10. Gabe R, Tryggvadottir L, Sigfusson BF, et al. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 2007; 48: 948-955.
11. Allgood PC, Warwick J, Warren RM, et al. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008; 98: 206-209.
12. Puliti D, Miccinesi G, Collina N, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 2008; 99: 423-427.
13. Walter SD. Mammographic screening: case-control studies. Ann Oncol 2003; 14: 1190-1192.
14. Verbeek ALM and Broeders MJM. Evaluation of cancer service screening: case referent studies recommended. Stat Meth Med Res 2010; 19: 487-505.
15. Kopec JA and Esdaile JM. Bias in case-control studies. A review. J Epidemiol Commun Health 1990; 44: 179-186.
16. Cronin KA, Weed DL, Connor RJ, et al. Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 1998; 90: 498-504.
17. Hosek RS, Flanders WD and Sasco AJ. Bias in case-control studies of screening effectiveness. Am J Epidemiol 1996; 143: 193-201.
18. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast-cancer screening-viewpoint of the IARC Working Group. N Engl J Med 2015; 372: 2353-2358.
19. Moss SM. Case-control studies of screening. Int J Epidemiol 1991; 20: 1-6.
20. Paap E, Verbeek AL, Puliti D, et al. Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol 2011; 22: 863-869.
21. Shapiro S, Venet W, Strax P, et al. Ten-to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982; 69: 349-355.
22. Friedman DR and Dubin N. Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol 1991; 133: 974-984.
23. Gullberg B, Andersson I, Janzon L, et al. Screening mammography. Lancet 1991; 337: 244.
24. Moss SM, Summerley ME, Thomas BT, et al. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Commun Health 1992; 46: 362-364.
25. van der Waal D, Broeders MJ, Verbeek AL, et al. Case-control studies on the effectiveness of breast cancer screening: insights from the UK Age Trial. Epidemiology 2015; 26: 590-596.
26. Moss SM, Cuckle H, Evans A, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet 2006; 368: 2053-2060.
27. Heinavaara S, Sarkeala T and Anttila A. Impact of organised mammography screening on breast cancer mortality in a case-control and cohort study. Br J Cancer 2016; 114: 1038-1044.
28. Sarkeala T, Heinavaara S and Anttila A. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. Int J Cancer 2008; 122: 614-619.
29. Johns LE, Coleman DA, Swerdlow AJ, et al. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Br J Cancer 2016; 116: 246-252.
30. Phillimore P, Beattie A and Townsend P. Widening inequality of health in northern England, 1981-91. BMJ 1994; 308: 1125-1128.
31. Broeders MJ, Verbeek AL, Straatman H, et al. Repeated mammographic screening reduces breast cancer mortality along the continuum of age. J Med Screen 2002; 9: 163-167.
32. Weiss NS, McKnight B and Stevens NG. Approaches to the analysis of casecontrol studies of the efficacy of screening for cancer. Am J Epidemiol 1992; 135: 817-823.
33. Broeders MJ and Verbeek AL. Mammographic screening only matters in the detectable preclinical period of breast cancer. J Med Screen 2005; 12: 107.
34. Paci E and Duffy SW. Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). Int J Epidemiol 1991; 20: 852-858.
35. Duffy SW, Day NE, Tabar L, et al. Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr 1997; 22: 93-97.
36. Weedon-Fekjaer H, Vatten LJ, Aalen OO, et al. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen 2005; 12: 172-178.
37. Svendsen AL, Olsen AH, von Euler-Chelpin M, et al. Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 2006; 106: 1883-1890.
38. van Schoor G, Moss SM, Otten JD, et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011; 104: 910-914.
39. Duffy SW and Cuzick J. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Stat 2002; 51: 235-243.
40. Connor RJ, Boer R, Prorok PC, et al. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. Am J Epidemiol 2000; 151: 991-998.
41. van den Akker-van Marle ME, de Koning H, Boer R, et al. Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom. J Med Screen 1999; 6: 30-34.
42. Paci E, Duffy SW, Giorgi D, et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 2002; 87: 65-69.
43. Advisory Committee on Breast Cancer Screening. Screening for breast cancer in England: past and future (NHSBSP publication no 61). J Med Screen 2006; 13: 59-61.
44. Alexander FE, Anderson TJ, Brown HK, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994; 70: 542-548.
45. Moritz S, Bates T, Henderson SM, et al. Variation in management of small invasive breast cancers detected on screening in the former south east Thames region: observational study. BMJ 1997; 315: 1266-1272.
46. Swerdlow AJ and Jones ME. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst 2005; 97: 375-384.